# Cyrano Therapeutics, Inc. — Form D

Cyrano Therapeutics, Inc. of WASHINGTON, DC, a company, filed a Form D exempt-offering notice with the SEC on 2020-11-16. The offering totals $12.8M, of which $4.1M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2020-11-16
- Form: D
- Accession: 0001832334-20-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $12.8M
- Amount sold: $4.1M
- Remaining: $8.7M
- Investors: 11
- Date of first sale: 2020-11-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-380646

## Issuer

- Name: Cyrano Therapeutics, Inc.
- CIK: 0001832334
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5125 MACARTHUR BLVD. NW, #20, WASHINGTON, DC, 20016
- Phone: 1 (925) 822-6461

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Gerry Brunk | Director | Ann Arbor, MI |
| Richard Geoffrion | Director | AMERICAN CANYON, CA |
| Robert Henkin | Director | Washington, DC |
| Takahide Koda | Director | Irvine, CA |
| Richard Geoffrion | Executive Officer | AMERICAN CANYON, CA |

## More

- [CIK 1832334 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1832334&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001832334-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.